Spore.bio

BYTES OF TOMORROW

Hey there,

As the holiday season unfolds, I wish you pure joy and a New Year filled with love and boundless possibilities. Here's to heartwarming moments and the exciting journey that lies ahead!

This newsletter will be the final one this year, and I hope to bring you more startup related information next year :)

Meet Spore.Bio, who’s building something unique to protect your life and lunch.

TL;DR

1. Funding Win: Spore.Bio secures €8M Pre-Seed funding led by LocalGlobe for its AI-driven pathogen detection tech in FMCG.

2. Tech Breakthrough: Developed a real-time, on-site device for instant bacteria concentration insights, reducing sampling time.

3. Efficiency Gains: Cuts quality sampling from 5-20 days to almost real-time, enhancing transparency for manufacturers.

4. Expert Team: Founded in 2023, led by CEO Amine Raji, with a skilled team and commercial contracts already in place.

5. Global Plans: With backing from investors like LocalGlobe, Spore.Bio aims for global deployment in 2023.

The Byte

You think you're safe when you're munching on your sandwich or applying that fancy cream on your face?

Think again!

Enter Spore.Bio, a deeptech startup that's here to save your ass (and your lunch).

They've just bagged a cool €8 million in Pre-Seed funding led by LocalGlobe.

Why?

They're tackling a ticking time-bomb in the global FMCG market: pathogens.

These little buggers are all over your food, drink, pharmaceuticals, and cosmetics.

Previously, detecting them was a pain. It took five to 20 days, with products shipped off to labs, burning time and money.

But Spore.Bio is changing the game.

They've built the world's first device that sniffs out these nasty pathogens right on the factory floor.

How?

With some wicked machine learning models.

The result?

Real-time insights with insane levels of traceability and transparency.

The company's dream team, led by CEO Amine Raji, CTO Maxime Mistretta, and COO Mohamed Tazi, built the first working version of this tech in less than eight months.

Impressive, huh?

And guess what?

They've already signed commercial contracts, and the waitlist for the first prototypes is oversubscribed.

Besides LocalGlobe, investors like EmergingTech Ventures, No Label Ventures, Roxane Varza (Station F), and more are backing them up.

So next time you're biting into your sandwich or applying your cream, remember this:

Spore.Bio is out there, making sure your products are as safe as can be.

Talk about a game-changer!

Careers

Spore.bio is hiring across engineering, technical operations and data. Please check out their careers page if you’re interested in making the world germ free!

Hope you loved this week’s newsletter!

Signing off,

FG